期刊文献+

hTERT在原发性肝癌中的表达及其临床意义 被引量:6

Expression and clinical significance of hTERT in hepatocellular carcinoma
下载PDF
导出
摘要 目的探讨端粒酶逆转录酶(hTERT)在原发性肝癌(HCC)中的表达,为肝癌早发现、治疗方案的选择、预后分析提供理论根据。方法 (1)采用免疫组化、RT-PCR法检测HCC及其癌旁组织和正常肝组织中hTERT基因表达水平。(2)比较hTERT检测和影像检查的诊断阳性率并对部分患者进行随访。结果 (1)hTERT在HCC和癌旁组织的阳性表达差异有显著性(P<0.01)。正常肝组织未见阳性表达。(2)hTERT检测诊断小肝癌阳性率高于影像学诊断;hTERT与影像学在癌旁组织的诊断阳性率差异有显著性(P<0.01)。(3)18例患者在随访期内有7例发生转移复发,均为hTERT阳性表达者。结论 (1)hTERT在肝癌组织中呈高表达水平;(2)hTERT在肝癌组织诊断中,小肝癌阳性率高于影像学诊断,癌旁组织诊断中,hTERT优于影像学诊断。(3)hTERT具有预示肝癌复发、转移的作用,可能成为辅助诊断和预后判断的指标之一。 Objective To investigate human telomerase reverse transcriptase (hTERT) expression in HCC tissues, provides the basic theory for HCC early detection, treatment choices, prognostic analysis. Methods ( 1 ) hTERT gene expression was detected by immunohistochemistry and RT- PCR methods in HCC and the tissues adjacent HCC and normal liver tissue; (2) to compare the positive diagnostics rate of image diagnosis and hTERT detection in HCC and follow up patients. Results ( 1 ) There was significant difference of hTERT expression between HCC and paracarcinomatous tissues (P 〈 0. 01 ). and no hTERT expression in normal liver tis- sues. (2) The positive rate of diagnosis in small HCC is higher than what imaging is;and there was significant difference of the positive diagnostics rate between hTERT and imaging (P 〈 0.01 ). (3) During the follow -up period, 7 cases of cancer metastasis or recur- rence were variable in 18 cases ,whom all had hTERT gene expression. Conclusions ( 1 ) hTERT in hepatocellular carcinoma tissues has a higher expression levels; (2) hTERT ,in diagnosis of HCC :the positive rates of hTERT is higher than that of imaging diagnosis in small HCC;In the diagnosis of tissue adjacent to carcinoma, hTERT is superior to imaging diagnosis. (3) hTERT has heralded the recurrence and metastasis of HCC, which maybe become a valuable marker for diagnosis and prognosis of HCC.
出处 《肝胆外科杂志》 2012年第3期218-221,共4页 Journal of Hepatobiliary Surgery
关键词 HTERT 原发性肝癌 癌旁组织 诊断 hTERT Hepatocellular carcinoma Paracareinomatous tissue Diagnosis
  • 相关文献

参考文献9

  • 1刘盛东(综述),黄成(审校),樊嘉(审校).肝癌的蛋白质组学研究进展[J].国际肿瘤学杂志,2009,36(4):301-303. 被引量:1
  • 2Qiu JG, Fan J, LiuYK, et al. Sercening and detection of portal vein tumor thrembi-associated serum low molecular weight protein bio- marker in human hepatoceilular carcinoma. Cancer Res Clinic. 2008, 134(3) :299 -305.
  • 3Butterfied LH, Bibas A, Dissette VB, et al. A phase Ⅰ / Ⅱ trial testing immunization of hepatocellular carcinoma patients with deadritic cells pals with four alpha-fetoprotein pepddes. Clin cancer Res ,2006,12 (9) :2817 -2825.
  • 4Li Y, Qin x, Cui JF,et al. Proteome analysis of atlatoxin Blindueed hepatocareinogenesis in tree shrew ( Tupaia belangeri chinenBiB1 and functional identification of candidate protein pemxiredoxin Ⅱ. Pre- teomies ,2008,8 (71 ) : 1490 - 1501.
  • 5Seimiya M, Tomonaga T, Matsushita K, et al. Identification of novel tumor markers for primary hepatocellular carci- noma; clathrin heavy chain and formiminotransferase cyclodeaminase Hepatology,2008, 48(2) :519 -530.
  • 6Nicholas A, Lanson JR, Paul L, et al. Friedlander Replication of an adenoviral vector controlled by the human telomerase reverse tran- scfiptase promoter causes tumor-selective tumor lysis. Cancer Res, 2003,63(8) :7936 -7941.
  • 7Gami M,Ikura Y,Nishiguchi S, et al. Quantitative analysis and insitu- alization of human telomerase RNA in chronic liver disease and hepa- toeellular carcinoma. Lab Invest,2004,79 ( 1 ) : 19 - 26.
  • 8Toshikuni N, Nouso K, Nakatsukasa H, et al. Expression of telomerase - associated protein 1 and telomerase reverse transcriptase in hepato- cellular carcinoma. British journal of Cancer, 2000,82 ( 4 ) : 833 - 837.
  • 9Suda T, Isokawa 0, Aoyagi Y, et al. Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant 1 iver. Hepatology, 1998,27 ( 2 ) :402 - 406.

二级参考文献19

  • 1Li L, Chen SH, Yu CH, et al. Identification of hepatocellular-carcinoma-associated antigens and antoantibodies by serological proteome analysis combined with protein microarray. J Proteome Res, 2008,7 (2) :611-620.
  • 2Tang ZY, Ye SL, Liu YK, et al. A decade ' s studies on metastasis of hepatecellular carcinoma. J Cancer Res Clin Oncol, 2004, 130 (4) :187-196.
  • 3Ding SJ, Li Y, Tan YX, et al. From proteomic analysis to clinical significance :overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics, 2004, 3 ( 1 ) : 73-81.
  • 4Cui JF, Liu YK, Pan BS, et al. Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins. J Cancer Res Clin Oncol, 2004, 130(10) :615-622.
  • 5Zhou H, Liu Y, Cui J, et al. Investigation on glycosylation patterns of proteins from human liver cancer cell lines based on the multi- plexed proteomies technology. Arch Biochem Biophys, 2007, 459 ( 1 ) :70-78.
  • 6Qiu JG, Fan J, Liu YK, et al. Screening and detection of portal vein tumor thrombi-associated serum low molecular weight protein biomarkers in human hepatocellular carcinoma. J Cancer Res Clin Oncol, 2008, 134(3) :299-305.
  • 7Wu N, Zhang W, Yang Y, et al. Profilin 1 obtained by proteomic analysis in all-trans retinoic acidtreated hepatocarcinoma cell lines is involved in inhibition of cell proliferation and migration. Proteomics, 2006, 6(22) :6095-6106.
  • 8Li Y, Qin X, Cui JF, et al. Proteome analysis of aflatoxin B- 1- induced hepatoearcinogenesis in tree shrew (Tupaia belangeri chinensis) and functional identification of candidate protein peroxiredoxin Ⅱ. Proteomics, 2008, 8(7) :1490-1501.
  • 9Luk JM, Lam BY, Lee NP, et al. Artificial neural networks and decision tree model analysis of liver cancer proteomes. Bioehem Biophs Res Commun, 2007, 361 ( 1 ) :68-73.
  • 10Seimiya M, Tomonaga T, Matsushita K, et al. Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma;clathrin heavy chain and formiminotransferase cyclodeaminase. Hepatology, 2008, 48(2) :519-530.

同被引文献71

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部